Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
Karim, M Y
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. [electronic resource] - Rheumatology (Oxford, England) Aug 2002 - 876-82 p. digital
Publication Type: Clinical Trial; Journal Article
1462-0324
10.1093/rheumatology/41.8.876 doi
Adult
Antibodies, Antinuclear--blood
Azathioprine--therapeutic use
Cyclophosphamide--therapeutic use
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--therapeutic use
Lupus Erythematosus, Systemic--blood
Male
Methotrexate--therapeutic use
Middle Aged
Mycophenolic Acid--analogs & derivatives
Proteinuria--prevention & control
Racial Groups
Statistics, Nonparametric
Time Factors
Treatment Failure
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. [electronic resource] - Rheumatology (Oxford, England) Aug 2002 - 876-82 p. digital
Publication Type: Clinical Trial; Journal Article
1462-0324
10.1093/rheumatology/41.8.876 doi
Adult
Antibodies, Antinuclear--blood
Azathioprine--therapeutic use
Cyclophosphamide--therapeutic use
Female
Follow-Up Studies
Humans
Immunosuppressive Agents--therapeutic use
Lupus Erythematosus, Systemic--blood
Male
Methotrexate--therapeutic use
Middle Aged
Mycophenolic Acid--analogs & derivatives
Proteinuria--prevention & control
Racial Groups
Statistics, Nonparametric
Time Factors
Treatment Failure